Filter

471 - 480 of 797 Results

  • Benefit Design and Formularies of Medicare Drug Plans: A Comparison of 2006 and 2007 Offerings

    Report

    This analysis provides a profile of the 2007 Medicare Part D stand-alone drug plans that are being offered to the program’s 43 million beneficiaries for 2007 and highlights some of the changes in plans between 2006 and 2007. It looks at premiums, covered drugs, the amount enrollees pay to fill a prescription, and other key features that would affect out-of-pocket costs and access to drugs for people with Medicare. The report describes the 1,875 stand-alone…

  • Health Care and the 2004 Elections

    Other Post

    ** Update: For information on health care and the 2008 election, visit www.health08.org. ** Health care issues continue to be important for many Americans and a vital part of the policy debates in Washington and around the country. During an election season, candidates propose and debate their solutions for the pressing policy issues facing their constituents. The 2004 election season is no different and the Kaiser Family Foundation is issuing informational materials on some of…

  • Impact of Pharmaceutical Promotion on the Use of Antidepressant Medication

    Other Post

    Two recent articles have been published on the impact of direct-to-consumer advertising (DTCA) on the use of antidepressants, based on research by researchers at Harvard University and the Massachusetts Institute of Technology, and funded in part by the Kaiser Family Foundation. These articles include: "Effects of Direct-to-Consumer Advertising on Medication Choice: the Case of Antidepressants," Journal of Public Policy and Marketing, 23(2):115-127, Fall 2004 (J.M. Donohue and E.R. Berndt). This research found that DTCA for…

  • Americans Value the Health Benefits of Prescription Drugs, But Say Drug makers Put Profits First, New Survey Shows – Toplines

    Poll Finding

    The most recent Kaiser Health Poll Report found that Americans believe prescription drugs are improving their lives, but most also say that the drug industry cares more about profits than people. The current report analyzes the new data as well as related polling information from earlier surveys by the Kaiser Family Foundation and other organizations. News Release Survey Toplines (.pdf)

  • Kaiser Family Foundation/ Harvard School of Public Health Medicare Prescription Drug Survey

    Report

    A new survey by the Kaiser Family Foundation and Harvard School of Public Health examines public opinion on the current Medicare prescription drug debate. The survey, a follow-up to a broader, more comprehensive survey released in June 2003 about the Medicare program and proposed changes, finds that a majority of seniors want Congress to pass Medicare prescription drug legislation this year, but most worry that they will still pay too much for drugs even if…

  • The Medicare Prescription Drug Law – What Are Seniors Saying?

    Other Post

    As the first phase of the new Medicare prescription drug law takes effect, the Kaiser Family Foundation commissioned focus groups conducted by Bill McInturff of Public Opinion Strategies and Geoff Garin of Peter D. Hart Research Associates in consultation with Foundation staff. The focus groups were designed to explore what people on Medicare know and think about the discount drug card that went in effect June 1st, and the new benefit that takes effect in…

  • Medicare Part D 2008 Data Spotlight: Ten Most Common Brand-Name Drugs

    Issue Brief

    This Medicare Part D Data Spotlight examines the variation in 2008 Part D plan coverage, cost sharing and utilization management tools for the 10 prescriptions most commonly used by Medicare beneficiaries, including treatments for cholesterol, cardiovascular health, osteoporosis, dementia, gastrointestinal reflux and ulcers. It looks at data from the 47 stand-alone prescription drug plans available nationwide in 2008. This data spotlight is one in a series analyzing key aspects of the 2008 Medicare Part D…

  • Medicare Part D 2008 Data Spotlight: Low-Income Subsidy Plan Availability

    Issue Brief

    This Medicare Part D Data Spotlight focuses on the availability of drug plans for beneficiaries receiving the Part D low-income subsidy in 2008 and changes since 2006. It looks at data from the 47 stand-alone prescription drug plans available nationwide in 2008. This is one in a series analyzing key aspects of the 2008 Medicare Part D prescription drug plan choices. The analysis was conducted jointed by Jack Hoadley of Georgetown University, Elizabeth Hargrave of NORC…